HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Tuesday, March 25, 2014

US stocks end lower led by biotechnology sector

Indian ADRs witness a mixed finish though 


U.S. stocks bounced off session lows but still finished lower on Monday, 24 March 2014. 
Losses followed a drop in prices on Friday, which dented last week's gains. Equity indices began the session in the green, but quickly slumped into the red as biotechnology sector continued its recent woes while other momentum names displayed broad weakness. 

Late-afternoon buying lifted the key averages off their lows, but the Nasdaq could only reclaim a portion of its loss. Biotech and internet stocks were the biggest losers on the tech-heavy index. 

The Dow Jones Industrial Average shed 26.08 points, or 0.2%, to 16,276.69. The Nasdaq Composite finished the day 50.40 points, or 1.2%, lower at 4,226.39, paring some of the heavy losses at session lows. The S&P 500 index ended the day 9.08 points, or 0.5%, lower at 1,857.44. 

Apple, IBM and Microsoft gained between 0.9% and 1.2% with Apple's strength coming amid reports indicating the company is working on a content distribution agreement with Comcast about teaming up for a streaming-television service. 

Among other stocks under focus, Netflix shares declined 6.7%. Facebook dropped 4.7%, among the biggest S&P 500 losers. 

There was no notable economic data reported today, but some news of note came out of the G7 meeting at The Hague where the G7 nations issued a joint statement, saying they are suspending their participation in the G8 until "Russia changes course." 

The economic data point of the day Monday saw the China HSBC preliminary purchasing managers' index drop to an eight-month low of 48.1 in March from 48.5 in February. This continues a trend of weaker-than-expected economic data coming out of China and raises the question whether will China move to use monetary stimulus to boost its economy. The spate of weaker data from China has been a bearish underlying factor for many raw commodity markets. 

The U.S. flash PMI index came in Monday at 55.5 in March versus 57.1 in February. That data had little impact on the market place. Meantime, the European Union's March manufacturing flash PMI came in at 53.2 versus expectations of a 53.3 reading and a February figure of 53.3. A PMI reading below 50.0 suggests contraction and above 50.0 suggests growth. 

The Ukraine-Russia conflict is still on the radar screen of the market place. Any significant escalation of tensions between Ukraine and Russia would quickly put keener risk-aversion into the market place. 

Bullion prices ended substantially lower at Comex on Monday, 24 March 2014. Gold prices fell by nearly 2% on Monday to settle at their lowest level in more than five weeks as some traders bet on a U.S. interest-rate hike as early as next year, which could boost the dollar and pressure dollar-denominated prices for the metal. 

April gold fell $24.80, or 1.9%, to settle at $1,311.20 an ounce on the Comex division of the New York Mercantile Exchange. May silver fell 24 cents, or 1.2%, to end at $20.07 an ounce, with prices marking their sixth session decline in a row. 

Crude oil prices logged a minor gain on Monday, 24 March 2014 at Nymex as an oil spill caused the closure of one of the busiest seaports in the United States. Traders also continued to weigh the prospects for global crude-supply disruptions linked to Russia-Ukraine tensions, providing further support for oil prices, but weak economic data from China kept a cap on any gains 

Crude for May delivery rose 14 cents, or 0.1%, to settle at $99.60 a barrel on the New York Mercantile Exchange. 

Participation was in line with average as roughly 714 million shares changed hands at the NYSE. 

Indian ADRs ended mixed on Monday. In the IT space, Infosys was down 1% at $53.32 and Wipro shed 0.76% at $13.02. In the banking space, ICICI Bank rose 2.43% at $42.60 and HDFC Bank added 1.43% at $39.03. In the other sectors, Tata Motors was up 0.18% at 33.16 and Dr Reddy's Laboratories declined 0.67% at $44.60. 

Tomorrow, the Case-Shiller 20-city Index (consensus 13.3%) for January and the January FHFA Housing Price Index will be released at 9:00 ET while March Consumer Confidence (consensus 78.2) and New Home Sales for February will be reported at 10:00 ET.

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.